You are here: Industry Insights > Stelara

News List

EC approves expanded use of ustekinumab for ulcerative colitis europeanpharmaceuticalreview
September 09, 2019
The biologic treatment ustekinumab has been granted an expanded use for ulcerative colitis within the EU.
Janssen files Stelara in Europe for ulcerative colitis pharmatimes
January 08, 2019
Janssen has submitted a Group Type II Variation Application to the European Medicines Agency (EMA) seeking approval of Stelara (ustekinumab) for the treatment of adults with moderately to severely active ulcerative colitis (UC).
Janssen Submits Application to FDA for Stelara as Ulcerative Colitis Treatment americanpharmaceuticalreview
December 24, 2018
Janssen Pharmaceutical announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of.....
Janssen's Stelara shows promise across two dosages in ulcerative colitis pharmafile
November 20, 2018
Janssen’s biologic therapy Stelara (ustekinumab) has shown new efficacy in the treatment of moderate to severe ulcerative colitis in two dosage groups
New Data Released on Stelara for Ulcerative Colitis americanpharmaceuticalreview
October 12, 2018
Janssen announced new data showing treatment with a single intravenous (IV) dose of Stelara (ustekinumab) induces clinical remission and response in adults with moderate to severe ulcerative colitis (UC) who previously experienced an inadequate response o
Stelara induces remission in ulcerative colitis patients pharmatimes
October 11, 2018
Janssen has presented new data showing that a single dose of its biologic Stelara induced clinical remission and response in patients with moderate to severe ulcerative colitis.
STELARA Shows Positive Results In Treatment of Systemic Lupus Erythematosus americanpharmaceuticacreview
November 07, 2017
Based on the results of the Phase 2 study results, Janssen plans to advance STELARA into a Phase 3 SLE development program in 2018.
Janssen announces FDA approval of Stelara for plaque psoriasis europeanpharmaceuticalreview
October 17, 2017
The FDA has approved an expanded indication for Stelara for the treatment of adolescents with moderate plaque psoriasis…

Previous page 1 2 Next page